These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1899831)

  • 1. Ciprofloxacin inhibits human hematopoietic cell growth: synergism with tumor necrosis factor and interferon.
    Hahn T; Barak Y; Liebovich E; Malach L; Dagan O; Rubinstein E
    Exp Hematol; 1991 Mar; 19(3):157-60. PubMed ID: 1899831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells.
    Beran M; O'Brien S; Andersson B; McCredie KB; Gutterman JU
    Hematol Pathol; 1988; 2(2):65-71. PubMed ID: 3143710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development.
    Wang CQ; Udupa KB; Lipschitz DA
    J Cell Physiol; 1995 Jan; 162(1):134-8. PubMed ID: 7814445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor-alpha. Synergism with recombinant human IFN-gamma.
    Lu L; Srour EF; Warren DJ; Walker D; Graham CD; Walker EB; Jansen J; Broxmeyer HE
    J Immunol; 1988 Jul; 141(1):201-7. PubMed ID: 2454257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
    Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE
    J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta 1 enhances the suppression of human hematopoiesis by tumor necrosis factor-alpha or recombinant interferon-alpha.
    Sing GK; Keller JR; Ellingsworth LR; Ruscetti FW
    J Cell Biochem; 1989 Feb; 39(2):107-15. PubMed ID: 2715197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic humoral factor-gamma 2, an immunoregulatory peptide, enhances human hematopoietic progenitor cell growth.
    Barak Y; Hahn T; Pecht M; Karov Y; Berrebi A; Zaizov R; Stark B; Buchner V; Burstein Y; Trainin N
    Exp Hematol; 1992 Feb; 20(2):173-7. PubMed ID: 1544385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
    Taniguchi S; Dai CH; Krantz SB
    Exp Hematol; 1997 Mar; 25(3):193-8. PubMed ID: 9091293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
    Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE
    Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells.
    Murphy M; Perussia B; Trinchieri G
    Exp Hematol; 1988 Feb; 16(2):131-8. PubMed ID: 3123270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin alpha, and recombinant erythropoietin in serum-free cultures.
    Lu L; Welte K; Gabrilove JL; Hangoc G; Bruno E; Hoffman R; Broxmeyer HE
    Cancer Res; 1986 Sep; 46(9):4357-61. PubMed ID: 3089590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS; Ip G; Wright MA; Young MR
    Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased resistance of PIG-A- bone marrow progenitors to tumor necrosis factor a and interferon gamma: possible implications for the in vivo dominance of paroxysmal nocturnal hemoglobinuria clones.
    Barcellini W; Fermo E; Guia Imperiali F; Zaninoni A; Bianchi P; Boschetti C; Zanella A
    Haematologica; 2004 Jun; 89(6):651-6. PubMed ID: 15194531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro.
    Broxmeyer HE; Cooper S; Rubin BY; Taylor MW
    J Immunol; 1985 Oct; 135(4):2502-6. PubMed ID: 3928752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death.
    Selleri C; Sato T; Anderson S; Young NS; Maciejewski JP
    J Cell Physiol; 1995 Dec; 165(3):538-46. PubMed ID: 7593233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.